RAFAEL
ENRÍQUEZ DE SALAMANCA LORENTE
Investigador en el periodo 2009-2014
Publicaciones (48) Publicaciones de RAFAEL ENRÍQUEZ DE SALAMANCA LORENTE
2023
-
Diagnosis, evaluation and monitoring of acute hepatic porphyria
Medicina Clinica
-
Understanding Carbohydrate Metabolism and Insulin Resistance in Acute Intermittent Porphyria
International Journal of Molecular Sciences, Vol. 24, Núm. 1
2021
-
Acute intermittent porphyria, givosiran, and homocysteine
Journal of Inherited Metabolic Disease
2017
-
Prognostic models for locally advanced cervical cancer: External validation of the published models
Journal of Gynecologic Oncology, Vol. 28, Núm. 5
2015
-
Vitamin D-binding protein as a biomarker of active disease in acute intermittent porphyria
Journal of Proteomics, Vol. 127, pp. 377-385
2014
-
A novel mutation in the SLC40A1 gene associated with reduced iron export in vitro
American Journal of Hematology, Vol. 89, Núm. 7, pp. 689-694
2013
-
Familial porphyria cutanea tarda in Spain: Characterization of eight novel mutations in the UROD gene and haplotype analysis of the common p.G281E mutation
Gene, Vol. 522, Núm. 1, pp. 89-95
-
Functional associations of genetic variants involved in the clinical manifestation of erythropoietic protoporphyria in the Argentinean population
Journal of the European Academy of Dermatology and Venereology, Vol. 27, Núm. 6, pp. 754-762
2012
-
Molecular analysis of the UROD gene in 17 Argentinean patients with familial porphyria cutanea tarda: Characterization of four novel mutations
Molecular Genetics and Metabolism, Vol. 105, Núm. 4, pp. 629-633
-
Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis
Gene, Vol. 508, Núm. 1, pp. 15-20
-
Porfirias agudas en la unidad de cuidados intensivos
Emergencias
-
Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates.
Journal of translational medicine, Vol. 10, pp. 122
2011
-
Porfiriaconscientes
Más dermatología, Núm. 15, pp. 2-3
-
Tumour VEGF/Non Tumour VEGF protein expression ratio as a biomarker for survival in colorectal cancer patients
European Journal of Surgical Oncology, Vol. 37, Núm. 6, pp. 526-531
-
Two novel mutations in the SLC40A1 and HFE genes implicated in iron overload in a Spanish man
European Journal of Haematology, Vol. 86, Núm. 3, pp. 260-264
2010
-
Hepcidin treatment in Hfe-/- mice diminishes plasma iron without affecting erythropoiesis
European Journal of Clinical Investigation, Vol. 40, Núm. 6, pp. 511-517
2009
-
Epidermal growth factor receptor ligands in murine models for erythropoietic protoporphyria: Potential novel players in the progression of liver injury
Cellular and Molecular Biology, Vol. 55, Núm. 1, pp. 29-37
-
Identification and characterization of HMBS gene mutations in Spanish patients with acute intermittent porphyria
Cellular and Molecular Biology, Vol. 55, Núm. 2, pp. 55-63
-
In vivo effect an luteinizing hormone-releasing hormone analog on vascular endothelial growth factor and epidermal growth factor receptor expression in mammary tumors
Journal of Carcinogenesis, Vol. 8
-
Induction of hepatic aminolevulinate acid synthetase activity by isoflurane in a genetic model for erythropoietic protoporphyria
Cellular and Molecular Biology, Vol. 55, Núm. 1, pp. 38-44